LPHN3 is a brain-specific member of the G-protein coupled receptor family associated with both ADHD genetic susceptibility and methylphenidate pharmacogenetics (Bruxel et al., 2015). This evidence concerns the gene ADGRL3 and attention deficit-hyperactivity disorder.